You have 9 free searches left this month | for more free features.

City

Beijing (1)

Chicago (1)

Nashville (1)

Saint Louis (1)

Sarasota (1)

Tempe (1)

Condition

Advanced Hepatocellular Carcinoma (HCC) (1)

Healthy (1)

Metastatic Colorectal Cancer (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Enrolling by invitation (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

Elevar Therapeutics (2)

Jiangsu HengRui Medicine Co., Ltd. (1)

Collaborator

Intervention

rivoceranib (3)

camrelizumab;rivoceranib (1)

regorafenib (1)

sorafenib (1)

trifluridine/tipiracil (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

rivoceranib

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Healthy Trial in Tempe (Rivoceranib)

Completed

Healthy

Rivoceranib

Tempe, Arizona

Celerion

Apr 15, 2022

Metastatic Colorectal Cancer Trial in United States (Rivoceranib, Trifluridine/Tipiracil)

Active, not recruiting

Metastatic Colorectal Cancer

Rivoceranib
Trifluridine/Tipiracil

Sarasota, Florida
+3 more

May 18, 2022

Advanced Hepatocellular Carcinoma (HCC) Trial in Beijing (camrelizumab;Rivoceranib, Rivoceranib, Sorafenib)

Enrolling by invitation

Advanced Hepatocellular Carcinoma (HCC)

camrelizumab；Rivoceranib
+3 more

Beijing, Beijing, China

Chinese PLA General Hospital

Oct 21, 2021